WHO Infertility Guideline One-Year Review: Global Progress on Fertility Care Access

In November 2025, the WHO launched its first global infertility guideline, setting forth 40 recommendations aimed at safer, fairer, and more accessible fertility care across the world.

Now, nearly one year later, the critical question for patients considering fertility treatment is no longer simply what the guideline says, but whether the care you need is becoming easier to reach.

Progress differs widely from country to country. It depends on where you live, or which destination you choose for cross-border IVF. Some countries are tightening clinical standards; others are expanding insurance coverage; and some are starting by subsidising diagnostic care only.

China: Where Insurance Coverage Has Scaled Nationwide

Starting in 2025, all 31 provincial-level administrative regions plus the Xinjiang Production and Construction Corps in China have incorporated selected assisted-reproduction procedures into public medical insurance.

Official government data for the first half of 2026 (from China’s National Healthcare Security Administration):

n 1.7096 million insured treatment visits;

n Over ¥1.9 billion in insurance spending;

n Around 139 700 babies were born from treatment cycles covered under this policy.

The five most-utilised reimbursed procedures are embryo transfer, sperm processing and selection, embryo culture, egg retrieval and ICSI. 

National authorities are working toward unifying reimbursement rules across provinces to reduce regional gaps.

What This Means for You

Public insurance lowers financial barriers and boosts treatment access. Even with insurance, real-world access still depends on clinic locations, capacity and clear patient information.

The U.K.: Where Standards Are Tightening

One of the clearest signs of the guideline’s influence is in clinical standard-setting.

March 2026, NICE updated its fertility guidance to adopt WHO semen reference values (16 million/mL sperm concentration, 42% total motility). It also confirms eligible women under 40 should get up to three publicly-funded IVF cycles.

This update does not expand patient numbers, but sets clearer clinical benchmarks. When comparing clinics or countries, providers following WHO-aligned standards meet recognised international norms.

For more on advanced sperm testing, read our guide to [How to increase Sperm Count].

The U.S.: Where Coverage Is Expanding

In the United States, there is no federal mandate for IVF coverage. As of 2026, 25 states and Washington, D.C. have laws requiring some form of fertility insurance coverage, but only 15 states plus D.C. specifically mandate IVF coverage.

Costs vary wildly based on your state and employer. WHO advocates universal fertility-care access, but progress in the U.S. happens state-by-state. Most rules apply only to large-group plans and exclude self-insured employers.

What This Means for You

If you are considering treatment in the U.S., the first practical step is to confirm your specific plan’s IVF benefits, not just whether your state has a mandate.

Vietnam: Phased Approach

In August 2026, Vietnam’s obstetrics-gynecology association reviewed the WHO guideline and proposed phased insurance support: first reimburse consultations, blood work and ultrasound diagnostics, before covering fertility treatments.

Vietnam’s Ministry of Health plans to release its national assisted-reproduction guideline (built on WHO standards) by late 2026-early 2027.

What This Means for You

This is a meaningful signal for cross-border care. It suggests that in some destinations, the regulatory and diagnostic infrastructure is being strengthened before broad insurance coverage arrives.

For patients, that can mean greater consistency in initial evaluation, even if treatment costs remain largely out-of-pocket.

Southeast Asia: Where the Work Is Regional

In the WHO South-East Asia Region, implementation is happening first at the regional level.

WHO SEARO held a regional webinar in April 2026. Assessments show fragmented, inequitable fertility services and gaps in local governance. The 2026-2030 regional sexual-reproductive-health strategy now formally includes infertility care.

What This Means for You

For patients considering treatment in Southeast Asia (such as Thailand), this means the standards environment is improving, but the pace varies by country.

The regional assessment is a baseline, not a guarantee of uniform service quality on the ground.

What This Means for Your Decision

Three practical points stand out.

Guidelines Doesn’t Guarantee Accessible Care

The WHO guideline shows what good fertility care should include, but it doesn’t mean every clinic or country can offer it right away.

Access still depends on insurance, public funding, and local clinic capacity. When you compare IVF destinations, look beyond “follows WHO guidance” and check what services are covered and available in practice.

Fertility Care Is Slowly Becoming Part of Mainstream Medicine

Around the world, countries are moving away from treating infertility as an entirely private, out-of-pocket service.

Some update clinical standards, some roll out insurance benefits, and others start by covering basic diagnostic tests. This shift is gradual, but it points to better, fairer fertility care over time.

Pick a Destination That Fits Your Needs

The best plan for you depends on where you are treated.

If you are in a place where insurance coverage is expanding, the next step is to find out exactly what your plan covers. If you are considering treatment abroad, the key question is whether that clinic follows recognised international standards.

The Bottom Line

A year after its release, the WHO guideline’s most important effect is not a single policy change in a single country.

It is that countries now have a common reference point against which to measure their own progress, and patients have a clearer way to ask whether the care they are being offered meets an international standard. The gap between standard and access remains wide. But the direction is visible.

For more information about fertility care standards and cross-border options, email info@cefivf.com or visit our Contact page.

This article is based on publicly available information from WHO, NICE, KFF, National Healthcare Security Administration of China, and regional health authorities as of 2026. It is for informational purposes only and does not constitute medical or legal advice.